Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,616.85
(
0.08%
)
US TECH 100
24,198.00
(
2.80%
)
Dow Jones
46,584.46
(
-0.18%
)
Brent Oil
93.93
(
-7.20%
)
Bitcoin
71,846.72
(
-0.20%
)
News Focus
News Focus
Post# of 820709
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

CrashOverride

Send PM Follow Ignore
Followers 96
Posts 5080
Boards Moderated 0
Alias Born 02/07/2021

CrashOverride

Re: biosectinvestor post# 555944

Tuesday, 01/03/2023 2:56:46 PM

Tuesday, January 03, 2023 2:56:46 PM

Post# of 820709
NICE only reviews a drug after it's been approved by MHRA. They don't have NHS subsidize drugs which are not approved by MHRA. So given NICE are already involved in determining if they will reimburse the cost of DCVax, I believe the firm are well ahead of what they disclosed at the 2022 ASM.

Do your own research. I am not providing legal or investment advice. This is an anonymous forum for entertainment purposes only. Don't trust anything you read.

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News